Breakthrough T1D and the International Society for Pediatric and Adolescent Diabetes (ISPAD) are thrilled to announce the 2022 recipients of the Allan Drash Clinical Fellowships—and they’re an incredible bunch.
They are:
- Muzna Arif, Pakistan
- Moomin Hussain Bhat, India
- Emine Ayça Cimbek, Turkey
- Hiba Elshafie, Sudan
- Elif Eviz, Turkey
- Berna Eroğlu Filibeli, Turkey
- Sara Gafar, Sudan
- Erdal Kurnaz, Turkey
- Marzhan Rakhimzhanova, Kazakhstan
- Prusha Mohammed Salih, Iraq
What Are Allan Drash Clinical Fellowships?
T1D is a global program—a problem whose unfortunate scope is just now being fully realized through the T1D Index. For years, ISPAD and Breakthrough T1D have been committed to equipping healthcare professionals around the world with the skills, knowledge, and connections to make a difference in their communities through the Drash Fellowships.
Each year, the Fellows are chosen from a competitive candidate pool of applicants from middle-income and developing nations and receive a stipend to spend 6 weeks at an ISPAD Center of Excellence. These Centers are cutting edge diabetes care providers, staffed with expert clinicians. Each fellow spends their time learning from the best—information that allows them to provide the best possible care to their local diabetes communities. After 6 weeks, they take this life-saving information back home, transforming diabetes care in their communities.
These fellowships have a real-world impact. There are dozens of clinicians in countries all over the world that are now able to provide the best possible care to their patients—which would not have been possible without these fellowships.
Don’t just take our word for it—hear from the 2020 Fellows.
Congratulations to the 2022 Fellows!
